Home⇛The PCMC Journal⇛vol. 15 no. 2 (2019)

Survival of Filipino Children with Acute Lymphoblastic LeukemiaDiagnosed in a Tertiary Referral Center for Childhood Cancer:A Retrospective Cohort Study

Trixy G. Chu | Arden Mae S. Shiu | Ma. Beatriz P. Gepte | Ma. Cecilia Leongson-Cruz

 

Abstract:

BACKGROUND: Acute lymphoblastic leukemia (ALL) represents the largest group of pediatric malignancies. The high cure rate of childhood ALL represents one of the most remarkable success stories in the war against cancer. In a lower middle income country (LMIC) like the Philippines, we reviewed the 5-year survival in a tertiary referral center. OBJECTIVES: This study aims to determine the 5-year survival of childhood ALL at a tertiary referral center for childhood cancer. METHODOLOGY: Medical charts of newly diagnosed ALL ages 1 to 18 years old from January 2012 to December 2016 were reviewed. OUTCOME: A total of 435 subjects were included in the study. The 5-year overall survival (OS) and event free survival (EFS) were 65.3% and 62.8%, respectively. The 5-year OS for standard risk ALL was 68.8% and for high risk ALL was 50%. The 5-year OS for the remission group was 83.7% and for the relapse was 21.1%. Univariate and multivariate analysis showed that WBC count at diagnosis, risk classification, immunophenotyping, and relapse showed significant prognostic impact for mortality. CONCLUSION: The 5-year OS and EFS were lower compared to developed countries but are comparable with other LMICs. The prognostic factors for relapse and mortality were compatible with the literature. Overall, the adopted treatment protocols for childhood ALL in this institution showed acceptable results.



References:

  1. Howard SC, Metzger ML, Williams JA, Quintana Y, Pui CH, Robison LL, Ribeiro RC. Childhood cancer epidemiology in low-income countries. Cancer. 2008 Feb 1;112(3):461-72.
  2. Bonilla M, Gupta S, Vasquez R, Fuentes S, DeReyes G, Ribeiro R, Sung L. Predictors of outcome and methodological issues in children with acute lymphoblastic leukemia in El Salvador. Eur J Cancer. 2010;46(18):3280-6.
  3. Pui CH. Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc. 2010;109(11):777-87.
  4. Harrison C. Acute lymphoblastic leukemia. Best Pract Res Clin Haematol. 2001;14(3):593-607.
  5. Kebriaei T, Anastasi J, Larson R. Acute lymphoblastic leukemia: diagnosis and classification. Best Pract Res Clin Haematol. 2002;15(4):597-621. doi:10.1053/beha.2002.0224.
  6. Redaniel MT, Laudico A, Mirasol-Lumague MR, Alcasabas AP, Pulte D, Benner H. Geographic and ethnic differences in childhood leukaemia and lymphoma survival: comparisons of Philippine residents, Asian Americans and Caucasians in the United States. Br J Cancer. 2010;103(1):149-54.
  7. Galano J, Gepte MB. Five-year survival outcome of acute lymphoblastic leukemia in Philippine Children’s Medical Center 2003-2007. [Unpublished].
  8. Niemeyer CM, Sallan SE. Acute lymphoblastic leukemia. In: Nathan DG, Orkin SH, editors. Nathan and Oski’s hematology of infancy and childhood. 5th ed. Philadelphia: WB Saunders; 1998. p.1245-85.
  9. Carroll W, Raetz E. Building better therapy for children with acute lymphoblastic leukemia. Cancer Cell. 2005 Apr;7(4):283-91.
  10. Sackmann-Muriel F, Felice MS, Zubizarreta PA, Alfaro E, Gallego M, Rossi J, et al. Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM’90 protocol: lack of improvement in high-risk group. Leuk Res. 1999;23(4):331-40.
  11. Laks D, Longhi F, Wagner M, Garcia PC. Survival evaluation of children with acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munich trial. J Pediatr (Rio J). 2003;79(2):149-58.
  12. Dujua AC, Hernandez FG. Survival outcome of Filipino children with acute lymphoblastic leukemia treated with modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) protocol in a tertiary general hospital from January 2005 to December 2009: a retrospective cohort study. J Pediatr Hematol Oncol. 2017 Apr;39(3):e116-23.
  13. Bhojwani D, Howard SC, Pui CH. High-risk childhood acute lymphoblastic leukemia. Clin Lymphoma Myeloma. 2009;9 Suppl 3:S222. doi:10.3816/CLM.2009.s.016.
  14.  Alexander S. Clinically defining and managing high-risk pediatric patients with acute lymphoblastic leukemia. Insights from pediatric hematologic malignancies: focus on acute lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2014;2014:71-8.
  15. Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME, Sather HN, Hunger SP, Devidas M. Long-term results of the Children’s Cancer Group studies for childhood acute lymphoblastic leukemia 1983–2002: a Children’s Oncology Group report. Leukemia. 2010;24(2):285-97. doi:10.1038/leu.2009.262.
  16. Steinherz PG, Redner A, Steinherz L, Meyers P, Tan C, Heller G. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. Cancer. 1993 Nov 15;72(10):3120-30.
  17. Winick NJ, Smith SD, Shuster JJ, et al. Treatment of CNS relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1993;11(2):271-8.
  18. Barredo JC, Devidas M, Lauer SJ, Billett AL, Marymont MA, Pullen J, Camitta B, Winick N, Carroll WL, Ritchey AK. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a Pediatric Oncology Group study. J Clin Oncol. 2006 Jul 1;24(19):3142-9.
  19.   Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166-78.
  20. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood. 2003;101(10):3809-17.
  21. Ellison LF, Pogany L, Mery LS. Childhood and adolescent cancer survival: a period analysis of data from the Canadian Cancer Registry. Eur J Cancer. 2007;43(13):1967-75.
  22. Doll R. Are we winning the fight against cancer? An epidemiological assessment. EACR-Muhlbock Memorial Lecture. Eur J Cancer. 1990;26(4):500-8.
  23. Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children’s Oncology Group. J Clin Oncol. 2012;30(14):1663-9.
  24. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukemia. Lancet. 2008;371(9617):1030-43.
  25. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996;14(1):18-24.
  26. Vaitkevičienė G, Matuzevičienė R, Stoškus M, Žvirblis T, Ragelienė L, Schmiegelow K. Cure rates of childhood acute lymphoblastic leukemia in Lithuania and the benefit of joining international treatment protocol. Medicina (Kaunas). 2014;50(1):28-36. doi:10.1016/j.medici.2014.05.005.
  27. Prodanova K, Yurukova N. Survival analysis for data of pediatric acute leukemia in Bulgaria. Biotechnol Biotechnol Equip. 2013;27(2):3689-94. doi:10.5504/BBEQ.2012.0122.
  28. Bonilla M, Gupta S, Vasquez R, Fuentes S, de Reyes G, Ribeiro R, Sung L. Predictors of outcome and methodological issues in children with acute lymphoblastic leukemia in El Salvador. Eur J Cancer. 2010;46(18):3280-6.
  29. Hossain J, Xie L, McCahan SM. Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis. J Cancer Epidemiol. 2014;2014:865979. doi:10.1155/2014/865979.
  30. Bhojwani D, Pui CH. Relapsed childhood acute lymphoblastic leukemia. Lancet Oncol. 2013;14(6):e205-17.
  31. Sekarn P, Wiangnon S, Veerakul G, Chotsampancharoen V, Kanjanapongkul S, Chainansamit S. Outcome of childhood acute lymphoblastic leukemia treated using the Thai national protocols. Asian Pac J Cancer Prev. 2015;16(11):4609-14. doi:10.7314/APJCP.2015.16.11.4609.
  32. Zouain-Figueiredo GP, Zandonade E, Costa Amorim MH. Cancer survival among children and adolescents at a state referral hospital in southeastern Brazil. Rev Bras Saude Matern Infant. 2013;13(4):335-44.
  33. Chan KW. Acute lymphoblastic leukemia. Curr Probl Pediatr Adolesc Health Care. 2002;32(1):40-9. doi:10.1067/mps.2002.121790.
  34. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukemia. Lancet. 2013;381(9881):1943-55. doi:10.1016/S0140-6736(12)62187-4.
  35. de Oliveira BM, Valadares MT, Silva M, Viana M. Compliance with a protocol for acute lymphoblastic leukemia in childhood. Rev Bras Hematol Hemoter. 2011;33(3):185-9. doi:10.5581/1516-8484.20110051.
  36. Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer. 2007;49(7):941-6.
  37. Yeoh AE, Tan D, Li CK, Hori H, Tse E, Pui CH. Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol. 2013;14(12):e508-23. doi:10.1016/S1470-2045(13)70452-2.
  38. Gao YJ, Qian XW, Lu FJ, et al. Improved outcome for children with non-high risk acute lymphoblastic leukaemia after using an ALL IC-BFM 2002-based protocol in Shanghai, China. Br J Haematol. 2013;160(3):363-7.
  39. Stary J, Zimmermann M, Campbell M, et al. Results of the randomized “I-BFM-SG trial acute lymphoblastic leukemia intercontinental-BFM 2002” in 5060 children diagnosed in 15 countries on 3 continents. Blood. 2011;118:Abstract 872.
  40. Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Pattern of mortality in childhood acute lymphoblastic leukemia: experience from a single center from northern India. J Pediatr Hematol Oncol. 2010;32(5):366-9.
  41. Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(3):e577. doi:10.1038/bcj.2017.53.
  42. Bleyer A, Barr R, Ries L, Whelan J, Ferrari A. Cancer in adolescents and young adults. Cham: Springer; 2016.
  43. Marjerrison S, Antillon F, Fu L, Martinez R, Vasquez R, Bonilla M, et al. Outcome of children treated for relapsed acute lymphoblastic leukemia in Central America. Cancer. 2013;119(7):1277-83. doi:10.1002/cncr.27846.

Tools


Copyright © 2025  KITE Digital Educational Solutions |  Exclusively distributed by CE-Logic